Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Chemical & Pharmaceutical Bulletin|December 4, 2003
Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activationShinichi Uesato, Keisuke Taniuchi, Ayako Kumagai, et al.
Biological & Pharmaceutical Bulletin|January 8, 2008
Comparative examination of anti-proliferative activities of (-)-epigallocatechin gallate and (--)-epigallocatechin against HCT116 colorectal carcinoma cellsHiroyuki Inaba, Yasuo Nagaoka, Yukihiro Kushima, et al.
Bioorganic & Medicinal Chemistry|May 11, 2010
New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino groupShingo Kiyokawa, Yoshiyuki Hirata, Yasuo Nagaoka, et al.
Neurobiology of Aging|November 8, 2015
A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's diseaseChi-Jing Choong, Tsutomu Sasaki, Hideki Hayakawa, et al.
Chemical & Pharmaceutical Bulletin|November 2, 2011
Antitumor effect of liposomal histone deacetylase inhibitor-lipid conjugates in vitroYoshiyuki Hattori, Yasuo Nagaoka, Manami Kubo, et al.
Biological & Pharmaceutical Bulletin|May 3, 2005
Inhibitory effects of cancer cell proliferation by novel histone deacetylase inhibitors involve p21/WAF1 induction and G2/M arrestTaishi Maeda, Yasuo Nagaoka, Yuki Kawai, et al.
Neuroscience Letters|October 4, 2005
Cytoprotective effect of novel histone deacetylase inhibitors against polyglutamine toxicityShingo Kariya, Makito Hirano, Shinichi Uesato, et al.
Bioorganic & Medicinal Chemistry|June 14, 2011
New microtubule polymerization inhibitors comprising a nitrooxymethylphenyl groupYasuyuki Kawaratani, Tomohiko Harada, Yoshiyuki Hirata, et al.
Pageof 4